Skip to main content
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Nat Rev Drug Discov. 2011 Jun;10(6):409–410. doi: 10.1038/nrd3462

Figure 1.

Figure 1

Figure 1

Figure 1

Therapeutic (A) and target-class focus (B) (see supplemental information, survey questions 14 and 15). The undisclosed targets result from a small number of centers providing no information. (C) Sources of hits by discovery strategy. The figure indicates tractable hits that originated from each strategy averaged over all respondents (see supplemental information, survey question 19).